--- title: "Licensed Bulk Medicines" ocid: "ocds-h6vhtk-03d4f5" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-03d4f5" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-03d4f5.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-03d4f5.json" source: "Find A Tender Service" current_stage: "Planning" buyer: "VELINDRE NHS TRUST, NHS WALES SHARED SERVICES PARTNERSHIP — PROCUREMENT SERVICES (ON BEHALF OF ALL WALES LHB'S AND TRUSTS)" published: "2023-06-09" --- # Licensed Bulk Medicines Buyer: VELINDRE NHS TRUST, NHS WALES SHARED SERVICES PARTNERSHIP — PROCUREMENT SERVICES (ON BEHALF OF ALL WALES LHB'S AND TRUSTS) Current stage: Planning OCID: ocds-h6vhtk-03d4f5 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-03d4f5) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-03d4f5.json) ## Summary The Velindre NHS Trust, NHS Wales Shared Services Partnership is planning a tender for purchasing Licensed Bulk Medicines with an estimated value of £42,317,736.61 per annum. The products will be available in licensed bulk containers over a 5-year timeframe. The tender falls under the pharmaceutical products classification and is open for suppliers who can meet the specified presentation requirements. The procurement stage is currently in the planning phase, and interested parties can expect future notices by January 1, 2025. This tender opportunity presents a lucrative chance for pharmaceutical suppliers to engage in supply contracts with the NHS in Wales. Businesses specializing in pharmaceutical products, particularly those capable of providing licensed bulk presentations, are well-suited to compete in this tender. The Velindre NHS Trust acts as the purchasing authority, and the procurement process is governed by public law, focusing on Health-related goods procurement in the UK. ## Notice We are interested in buying the following list of products, in licensed bulk containers of up to the sizes noted below, to be available within a 5 year timeframe. We consider the availability in licensed bulk presentation to be a significant market advantage and are willing to consider entering contracts for supply with suppliers who can meet this presentation requirement for these products. Estimated value in the Wales market of this list is PS42,317,736.61 p/a at current prices. The list is not exhaustive, and we are willing to consider other generic and biosimilar products if licensed bulk presentation can be offered. Drug,Strength,Proposed Vial Size ARSENIC TRIOXIDE,1mg/mL, AZACITIDINE,25mg/mL,500mL BEVACIZUMAB,25mg/mL,100mL - 250mL BORTEZOMIB,2.5mg/mL,50mL CALCIUM FOLINATE,10mg/mL,1000mL CARBOPLATIN,10mg/mL,1000mL CETUXIMAB,5mg/mL,250m - 500mL CISPLATIN,1mg/mL,500mL - 1000mL CYCLOPHOSPHAMIDE,20mg/mL,500mL CYTARABINE,100mg/mL or 20mg/mL,250mL DARATUMUMAB,20mg/mL,100mL - 250mL DOCETAXEL,20mg/mL,250mL - 500mL DOXORUBICIN,2mg/mL,1000mL EPIRUBICIN,2mg/mL,1000mL ETOPOSIDE,20mg/mL,500mL FLUCLOXACILLIN,,3000mL FLUOROURACIL,50mg/mL or 25mg /mL,250-500mL INFLIXIMAB,10mg/mL,500mL - 1000mL IRINOTECAN,20mg/mL,1000mL NIVOLUMAB,10mg/mL,250mL OXALIPLATIN,5mg/mL,500mL-1000mL PACLITAXEL,6mg/mL,1000mL PEMBROLIZUMAB,25mg/mL,100mL - 250mL PEMETREXED,25mg/mL,100mL - 250mL PIPERACILLIN & TAZOBACTAM,,3000mL RITUXIMAB,10mg/mL,500mL TOCILIZUMAB,20mg/mL,250mL TRASTUZUMAB EMTANSINE,20mg/mL,100mL - 250mL VEDOLIZUMAB,60mg/mL,250mL VITLIPID N INFANT,N/A,250mL Please inform us via the contact information above if you are able to provide these products. ### Lot Information Lot 1 We are interested in buying the following list of products, in licensed bulk containers of up to the sizes noted below, to be available within a 5 year timeframe. We consider the availability in licensed bulk presentation to be a significant market advantage and are willing to consider entering contracts for supply with suppliers who can meet this presentation requirement for these products. Estimated value in the Wales market of this list is PS42,317,736.61 p/a at current prices. The list is not exhaustive, and we are willing to consider other generic and biosimilar products if licensed bulk presentation can be offered. Drug,Strength,Proposed Vial Size ARSENIC TRIOXIDE,1mg/mL, AZACITIDINE,25mg/mL,500mL BEVACIZUMAB,25mg/mL,100mL - 250mL BORTEZOMIB,2.5mg/mL,50mL CALCIUM FOLINATE,10mg/mL,1000mL CARBOPLATIN,10mg/mL,1000mL CETUXIMAB,5mg/mL,250m - 500mL CISPLATIN,1mg/mL,500mL - 1000mL CYCLOPHOSPHAMIDE,20mg/mL,500mL CYTARABINE,100mg/mL or 20mg/mL,250mL DARATUMUMAB,20mg/mL,100mL - 250mL DOCETAXEL,20mg/mL,250mL - 500mL DOXORUBICIN,2mg/mL,1000mL EPIRUBICIN,2mg/mL,1000mL ETOPOSIDE,20mg/mL,500mL FLUCLOXACILLIN,,3000mL FLUOROURACIL,50mg/mL or 25mg /mL,250-500mL INFLIXIMAB,10mg/mL,500mL - 1000mL IRINOTECAN,20mg/mL,1000mL NIVOLUMAB,10mg/mL,250mL OXALIPLATIN,5mg/mL,500mL-1000mL PACLITAXEL,6mg/mL,1000mL PEMBROLIZUMAB,25mg/mL,100mL - 250mL PEMETREXED,25mg/mL,100mL - 250mL PIPERACILLIN & TAZOBACTAM,,3000mL RITUXIMAB,10mg/mL,500mL TOCILIZUMAB,20mg/mL,250mL TRASTUZUMAB EMTANSINE,20mg/mL,100mL - 250mL VEDOLIZUMAB,60mg/mL,250mL VITLIPID N INFANT,N/A,250mL Please inform us via the contact information above if you are able to provide these products. ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/016383-2023 | | Notice type | Planning Notice | | Procurement type | Standard | | Procurement category | Goods | | Procurement method | Not Specified | | Procurement method details | Not specified | | Tender suitability | Not specified | | Awardee scale | Not specified | | All stages | Planning | ## Dates | Field | Value | | --- | --- | | Publication date | 9 Jun 2023 | | Submission deadline | Not specified | | Future notice date | 1 Jan 2025 | | Award date | Not specified | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £42,317,736 | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Planned | | Lots status | Planned | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | VELINDRE NHS TRUST, NHS WALES SHARED SERVICES PARTNERSHIP — PROCUREMENT SERVICES (ON BEHALF OF ALL WALES LHB'S AND TRUSTS) | | Locality | CARDIFF | | Post town | Cardiff | | Postcode | CF14 3UB | | Country | Wales | | ITL 1 | TLL Wales | | ITL 2 | TLL5 South East Wales | | ITL 3 | TLL52 Cardiff and Vale of Glamorgan | | Local authority | Cardiff | | Electoral ward | Gabalfa | | Westminster constituency | Cardiff North | | Delivery location | TLL Wales | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33600000 - Pharmaceutical products ## Release History - 9 Jun 2023 at 09:24 - Planning - Planning Notice - https://www.find-tender.service.gov.uk/Notice/016383-2023 ## Notice URLs - https://etenderwales.bravosolution.co.uk/ - https://nwssp.nhs.wales/ourservices/procurement-services/ ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-03d4f5. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-03d4f5.json.